Wayrilz (rilzabrutinib) is an approved therapy that’s used to increase platelet levels and lower the risk of bleeding in adults with persistent or chronic immune thrombocytopenia who have responded insufficiently to a previous treatment. It is administered as oral tablets.”
Immune thrombocytopenia
Whether you're newly diagnosed with ITP or have been managing it for some time, these resources offer guidance on symptoms, treatment options, and emotional support to help you move forward with confidence.
While there’s no cure for immune thrombocytopenia, a range of treatments — from steroids to platelet-boosting therapies — can help manage symptoms. Choosing the right plan depends on platelet levels, bleeding risk, and individual health considerations.
Latest news
Note: This story was updated Sept. 2, 2025, to clarify the definition of a durable platelet response used in LUNA 3. The U.S. Food and…
